Behavioral Addictions and Related NeuroCOgnitive Aspects
- Conditions
- Behavioral Addiction
- Registration Number
- NCT03967418
- Lead Sponsor
- Nantes University Hospital
- Brief Summary
Improving knowledge about behavioural addictions is a real public health issue. The etiopathogenic model of behavioural addictions is multifactorial, with various risk and vulnerability factors, involved in the initiation and maintenance of the disorders. Among these factors, neurocognitive alterations associated with behavioural addictions has recently aroused interest among researchers.
To our knowledge, there is no work wich compared several behavioural addictions with each other on a neurocognitive level. Moreover, neurocognitive data concerning certain behavioural addictions (such as sexual addiction) is almost non-existent. However, understanding the neurocognitive profiles of these patients would allow the investigators, on the one hand, to reinforce the existing literature and improve our understanding of the global process of addiction, and on the other hand, to propose alternative approaches to its management, taking into account the neurocognitive difficulties of the patients.
The investigators therefore propose to explore the neurocognitive alterations of patients suffering from several behavioural addiction (sexual addiction and eating disorders with bulimia episodes), by comparing them with each other, to matched healthy control groups and to a recognized behavioural addiction (gambling disorder; data from the BANCO study - NCT03202290).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 116
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Scores obtained at the various neurocognitive tests used 4 hours A composite score will be created to reflect the overall level of cognitive performance of individuals with behavioral addictions, compared to healthy controls
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
CHU de Nantes
🇫🇷Nantes, France
CHU de Nantes🇫🇷Nantes, FranceMarie GRALL BRONNEC, PrContact